Drug Discovery

Molecule design, trials and the pharma pipeline.

  • 41 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

  • +1 more

Latest in Drug Discovery


thedigitalship.com > news > electronics-navigation > hanwhas-ai-energy-system-targets-5-to-25-savings-as-fleet-energy-management-evolves

Hanwha’s AI energy system targets 5% to 25% savings as fleet energy management evolves

7+ hour, 57+ min ago   (289+ words) Hanwha’s EnergyFluo™ uses agentic AI to coordinate generation, storage and energy loads, with targeted savings of 5% to 25%. Its approach offers shipowners a useful model for managing increasingly complex vessel energy systems. Hanwha’s EnergyFluo™ has been named to Fast Company’s 2026 Next…...


sciencedaily.com > releases > 2025 > 06 > 250602155323.htm

Self-powered artificial synapse mimics human color vision

23+ hour, 37+ min ago   (92+ words) Overall, this work represents a significant step toward bringing the wonders of computer vision to edge devices, enabling our everyday devices to see the world more like we do. Materials provided by Tokyo University of Science. Note: Content may be…...


ksl.com > article > 51/63/3378 > life-sciences-firm-danaher-to-launch-ai-powered-autonomous-research-lab-in-2027

Life sciences firm Danaher to launch AI-powered autonomous research lab in 2027

1+ hour, 10+ min ago   (179+ words) Oct 7 — Life sciences company Danaher said on Wednesday ​it plans to launch its first AI-powered autonomous research lab early next ‌year to make drug discovery and development faster and more ⁠efficient. Here are more ​details: • The lab, projected ⁠to operate…...


tech.eu > 10/07/2026 > mintneuro-raises-5m-to-scale-chips-purpose-built-for-neural-devices

MintNeuro raises $5M to scale chips purpose-built for neural devices

1+ hour, 36+ min ago   (292+ words) MintNeuro, an Imperial College London spinout developing specialised chips for neural devices from implants to wearables, has raised $5 million to drive its commercial scale-up. The company is developing a semiconductor platform for devices that connect with the brain and nervous…...


nextluxury.com > mens-lifestyle-advice > why-hair-transplant-prices-vary-between-clinics

Why Hair Transplant Prices Vary So Much Between Clinics

1+ hour, 35+ min ago   (811+ words) What arrives later is harder to interpret. The improvement stops compounding, the mirror stops changing, and it becomes unclear whether the treatment has failed, whether the loss has accelerated, or whether nothing is wrong at all. That ambiguity is where…...


midfloridanewspapers.com > ap > business > carterra-advances-lab-in-the-loop-drug-discovery-through-new-scientific-collaboration > article_b9ed6ed9-ddac-5317-b64d-a40c8a7ff417.html

Carterra Advances Lab-In-The-Loop Drug Discovery Through New Scientific Collaboration

57+ min ago   (348+ words) SALT LAKE CITY--(BUSINESS WIRE)--Oct 7, 2026-- SALT LAKE CITY--(BUSINESS WIRE)--Oct 7, 2026--Carterra ®, a leading provider of high-throughput surface plasmon resonance (HT-SPRâ„¢) platforms for antibody and small molecule drug discovery, today announced a research collaboration with AstraZeneca…...


biotechnewswire.ai > 20/26/09082831 > heartbeat-bio-and-cubase-bio-partner-to-advance-3d-spatial-transcriptomics-for-cardiovascular-drug-discovery.html

HeartBeat.bio and Cubase Bio Partner to Advance 3D Spatial Transcriptomics for Cardiovascular Drug Discovery

48+ min ago   (1420+ words) €1M Eurostars funding supports joint development of a high-throughput 3D spatial profiling approach for myocardial fibrosis and heart failure drug discovery VIENNA, Austria and STOCKHOLM, Sweden, September 08, 2026 / Biotech Newswire / -- HeartBeat.bio AG, a TechBio company developing a human cardiac organoid-based drug discovery…...


tradingview.com > news > benzinga:7349b4239094b:0-meta-openai-and-anthropic-could-become-biotech-companies-says-stanford-neuroscientist-andrew-huberman-sounds-kind-of-science-fiction

Meta, OpenAI and Anthropic Could Become Biotech Companies, Says Stanford Neuroscientist Andrew Huberman: 'Sounds Kind of Science Fiction'

2+ hour, 56+ min ago   (270+ words) Stanford neuroscientist Andrew Huberman predicts Meta Platforms Inc. META, OpenAI and Anthropic could eventually become biotech companies, as the AI race expands into non-invasive technology for reading from and writing to the brain Neuroscience Is Now Part of the AI…...


openpr.com > news > 4653911 > care-management-solutions-market-gains-momentum-as-91-of-home

Care Management Solutions Market Gains Momentum as 91% of Home Care Leaders Embrace AI Adoption

3+ hour, 5+ min ago   (70+ words) openPR.com Care Management Solutions Market Gains Momentum as 91% of Home Care Leaders Embrace AI Adoption Press release from: DataM Intelligence 4 Market Research LLP Permanent link to this press release: You can edit or delete your press release Care Management…...


seas.harvard.edu > materials-science-mechanical-engineering

Materials Science & Mechanical Engineering

1+ hour, 53+ min ago   (613+ words) Materials Science and Mechanical Engineering at the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) offers comprehensive undergraduate and graduate programs that span from fundamental research in solid and fluid mechanics to innovative studies in materials, metamaterials, mechanical…...